Key Investor Conferences to Feature Aquestive Therapeutics
Aquestive Therapeutics to Participate in Upcoming Investor Conferences
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a leading pharmaceutical company committed to improving patient outcomes through cutting-edge science and delivery technologies, is pleased to announce its participation in two major investor conferences scheduled for September.
Details of the Conferences
The Aquestive Therapeutics management team will be presenting at the following events:
- H.C. Wainwright 26th Annual Global Investor Conference: The presentation is set for 8:30 am ET on the specified date and will include opportunities for one-on-one investor meetings.
- Lake Street BIG8 Conference: This event will also provide a platform for management to engage in meetings with investors.
Webcast Access for Investors
Investors unable to attend in person can access a live webcast of the H.C. Wainwright presentation via the "Events and Presentation" page in the Investors section of the company’s website. A replay of the presentation will be available for 30 days following the live event, allowing interested parties to review the insights shared.
About Aquestive Therapeutics
Aquestive is at the forefront of pharmaceutical innovation, focusing on the development of orally administered products designed to effectively deliver complex molecules. This approach provides new alternatives to traditional, often inconvenient, invasive therapies.
Commercial Successes
The company has successfully commercialized five products, which are distributed globally through licensing agreements. Aquestive remains the sole manufacturer of these products, highlighting its essential role in the supply chain.
Partnerships and Innovation
Aquestive partners with other pharmaceutical companies to bring new molecules to market. Utilizing proprietary technologies like the renowned PharmFilm® and its extensive drug development expertise, the company continually seeks to expand and enhance patient treatment options.
Future Product Pipeline
Aquestive is advancing a late-stage product candidate aimed at treating severe allergic reactions, including anaphylaxis. Additionally, the company is developing an early-stage prodrug topical gel product candidate for various dermatological conditions, demonstrating its commitment to broadening treatment options across different health challenges.
Investor Contact Information
For more information about Aquestive Therapeutics or its upcoming presentations, interested parties can contact their investor relations team:
ICR Westwicke
Stephanie Carrington
Email: stephanie.carrington@westwicke.com
Phone: 646-277-1282
Frequently Asked Questions
What is the purpose of the upcoming investor conferences?
The conferences allow Aquestive Therapeutics to present their latest innovations and engage with investors to discuss company developments and future prospects.
Who is invited to attend the presentations?
Investors, analysts, and other stakeholders interested in learning more about Aquestive Therapeutics are encouraged to attend the presentations and meetings.
Will there be a recording of the presentations available?
Yes, webcasts of the presentations will be available on the Company’s website, and replays will be accessible for 30 days after the events.
What type of products is Aquestive developing?
Aquestive is focused on developing innovative orally administered medications that provide alternatives to traditional therapies, including products for allergic reactions and dermatological conditions.
How can investors contact Aquestive for further inquiries?
Investors can contact the investor relations team via email at stephanie.carrington@westwicke.com or call 646-277-1282.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/